Cargando…

Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?

Background: Programmed death-ligand 1 (PD-L1) and programmed cell death protein 1 (PD-1) have been reported as possibly favorable prognostic factors in colorectal cancer (CRC). However, their longitudinal effect is unknown. Methods: A pilot study was performed to investigate whether baseline PD-1/PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dank, Magdolna, Mühl, Dorottya, Herold, Magdolna, Hornyák, Lilla, Szasz, Attila Marcell, Herold, Zoltan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410536/ https://www.ncbi.nlm.nih.gov/pubmed/36013050 http://dx.doi.org/10.3390/jcm11164815

Ejemplares similares

Longitudinal Analysis of 1α,25-dihidroxyvitamin D(3) and Homocysteine Changes in Colorectal Cancer
por: Mühl, Dorottya, et al.
Publicado: (2022)

High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study
por: Petenyi, Flora Greta, et al.
Publicado: (2021)

High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer
por: Barna, Andras Jozsef, et al.
Publicado: (2023)

Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system
por: Herold, Zoltan, et al.
Publicado: (2021)

The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience
por: Dank, Magdolna, et al.
Publicado: (2023)

Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas
por: Szasz, Attila Marcell, et al.
Publicado: (2023)

Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis
por: Herold, Zoltan, et al.
Publicado: (2020)

Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients
por: Kleef, Ralf, et al.
Publicado: (2023)

Influence of the duration of type 2 diabetes mellitus on colorectal cancer outcomes
por: Herold, Magdolna, et al.
Publicado: (2023)

Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes
por: Herold, Zoltan, et al.
Publicado: (2020)

Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts
por: Herold, Zoltan, et al.
Publicado: (2022)

Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases
por: Steinhoff, Heinrich, et al.
Publicado: (2023)

Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation
por: Ágoston, Emese Irma, et al.
Publicado: (2022)

Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
por: Herczeg, Gyorgy, et al.
Publicado: (2022)

Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin‐like cell hyperplasia and autoimmune gastritis
por: Herold, Zoltan, et al.
Publicado: (2020)

Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study
por: Szentmártoni, Gyöngyvér, et al.
Publicado: (2016)

Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist
por: Szasz, Attila M., et al.
Publicado: (2019)

Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment
por: Herold, Zoltan, et al.
Publicado: (2020)

New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
por: Nagy, Geza, et al.
Publicado: (2022)

Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer
por: Tőkés, Tímea, et al.
Publicado: (2019)

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
por: Acs, Miklos, et al.
Publicado: (2022)

Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer
por: Szendrői, Attila, et al.
Publicado: (2016)

Successful treatment of three synchronous primary malignant tumours—reflection on surgical, pathological and oncological aspects and decision making
por: Ágoston, Emese Irma, et al.
Publicado: (2018)

Correlation between Expression Profiles of Key Signaling Genes in Colorectal Cancer Samples from Type 2 Diabetic and Non-Diabetic Patients
por: Elek, Zsuzsanna, et al.
Publicado: (2020)

The role of stigma and depression in the reduced adherence among young breast cancer patients in Hungary
por: Vizin, Gabriella, et al.
Publicado: (2023)

Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity
por: Szeitz, Beáta, et al.
Publicado: (2023)

A survey of the burden of allergic rhinitis in Hungary from a specialist’s perspective
por: Szilasi, Mária, et al.
Publicado: (2012)

Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line
por: Kiss, Eva, et al.
Publicado: (2022)

Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
por: Brown, David, et al.
Publicado: (2017)

Erratum: Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
por: Brown, David, et al.
Publicado: (2017)

Methyl-Donors Can Induce Apoptosis and Attenuate Both the Akt and the Erk1/2 Mediated Proliferation Pathways in Breast and Lung Cancer Cell Lines
por: Kiss, Eva, et al.
Publicado: (2021)

The Effect of Dietary Methyl-Donor Intake and Other Lifestyle Factors on Cancer Patients in Hungary
por: Kiss, Eva, et al.
Publicado: (2022)

Psychological distress of patients suffering from restless legs syndrome: a cross-sectional study
por: Scholz, Hanna, et al.
Publicado: (2011)

Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations
por: Kajáry, Kornélia, et al.
Publicado: (2019)

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2− Advanced Breast Cancer: A Nationwide Real-World Experience
por: Boér, Katalin, et al.
Publicado: (2021)

Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer
por: Lammers, Philip E., et al.
Publicado: (2018)

Adaptive Immunity in Ankylosing Spondylitis: Phenotype and Functional Alterations of T-Cells before and during Infliximab Therapy
por: Szalay, Balázs, et al.
Publicado: (2012)

Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden
por: Bakos, Bence, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rn13s30j98kelusl1q165rm7m6